Latest Breaking News On - பாண்டியன் சிகிச்சை இன்க் - Page 1 : comparemela.com

Merck Completes Acquisition of Pandion Therapeutics Merck known as MSD outside the United States and Canada, today announced the successful completion of the cash tender offer, through a subsidiary, for all of the outstanding shares of common stock of Pandion Therapeutics, Inc. at a purchase price of $60 per share. As of the tender offer expiration, 27,770,123 shares of common stock of Pandion were validly tendered and not withdrawn from the tender offer, … Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the successful completion of the cash tender offer, through a subsidiary, for all of the outstanding shares of common stock of Pandion Therapeutics, Inc. (Nasdaq: PAND) at a purchase price of $60 per share. As of the tender offer expiration, 27,770,123 shares of common stock of Pandion were validly tendered and not withdrawn from the tender offer, representing approximately 88.6% percent of the outstanding common stock of Pandion on a fully

United statesFacebook instagram youtubePeter dannenbaumIan mcconnellMerck co incExchange commissionPandion therapeutics incStatement of merck co incPandion therapeuticsNasdaq global selectTwitter facebook instagram youtubeLooking statementSecurities litigation reform actஒன்றுபட்டது மாநிலங்களில்முகநூல் இன்ஸ்தக்ராம் வலைஒளிஈயந் ம்க்காநெல்